cyberliver.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | CyberLiver |
| Description | Re-inventing liver Home Products CirrhoCare ® AlcoChange® SteatoCare™ About Us News Contact Us Re-inventing liver care We are developing digital therapies for the treatment |
| Keywords | # |
Server Information
| WebSite | |
| Host IP | 188.114.96.3 |
| Location | Spain |
Related Websites
| Site | Rank |
More to Explore
cyberliver.com Valuation
|
US$1,365
Last updated: 2023-05-20 05:45:30
cyberliver.com has Semrush global rank of 0. cyberliver.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. cyberliver.com receives approximately 157 unique visitors each day. Its web server is located in Spain, with IP address 188.114.96.3. According to SiteAdvisor, cyberliver.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,365 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$37 |
| Yearly Ads Revenue | US$453 |
| Daily Unique Visitors | 10 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cyberliver.com. | A | 299 | IP: 188.114.96.3 |
| cyberliver.com. | A | 299 | IP: 188.114.97.3 |
| cyberliver.com. | AAAA | 299 | IPV6: 2a06:98c1:3121::4 |
| cyberliver.com. | AAAA | 299 | IPV6: 2a06:98c1:3120::4 |
| cyberliver.com. | NS | 86400 | NS Record: jaxson.ns.cloudflare.com. |
| cyberliver.com. | NS | 86400 | NS Record: asa.ns.cloudflare.com. |
| cyberliver.com. | MX | 300 | MX Record: 1 alt2.aspmx.l.google.com. |
| cyberliver.com. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
| cyberliver.com. | MX | 300 | MX Record: 1 aspmx3.googlemail.com. |
| cyberliver.com. | MX | 300 | MX Record: 1 alt1.aspmx.l.google.com. |
| cyberliver.com. | TXT | 300 | TXT Record: amazonses:xIs99byZBLWIMzBSJG6SkiQi22/Y51J7Gxg6Je2d3/s= |
| cyberliver.com. | TXT | 300 | TXT Record: google-site-verification=BitKNr2c6szJ3mup8hGMv6bV9997pUlVqbEN2XxG7Uc |
| cyberliver.com. | TXT | 300 | TXT Record: MS=E92D6F96ACF83A10F1139180E882C3F7A0E88D03 |
HtmlToTextCheckTime:2023-05-20 05:45:30
| Home Products CirrhoCare ® AlcoChange® SteatoCare™ About Us News Contact Us Re-inventing liver care We are developing digital therapies for the treatment of advanced liver disease. Liver disease is a global issue, the prevalence of which is staggering. It is estimated that more than 800 million people worldwide suffer from chronic liver disease and this figure is likely to grow given the ubiquity of alcohol use and obesity. End-stage liver disease – decompensated cirrhosis – carries with it a high human and healthcare cost. CyberLiver™ is developing Prescription Digital Therapeutics aimed at halting or reversing the progression of the disease towards this stage, as well as providing effective means of managing the very ill cohort of patients already at this stage. Management of Decompensated Cirrhosis Decompensated cirrhosis has a high morbidity and mortality rate and necessitates frequent visits to the emergency department, with regular hospitalisation. However, studies show that up |
HTTP Headers
HTTP/1.1 200 OK
Date: Fri, 13 Jan 2023 09:38:04 GMT
Content-Type: text/html
Connection: keep-alive
Last-Modified: Sat, 24 Dec 2022 07:24:32 GMT
Vary: Accept-Encoding,User-Agent
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=I7Hu2WihoocSomZkLwzM5%2FWl%2BYTuJL6o976Fn2N0kWODutDwTUUPhAHrJH5JQCltOgups1ANrG2pgj06r7JScLUP0ttPhtRzFMOayq%2F9QZ6tjtmsdNwVIKFH2noAMCb%2FifS09PwolHqtRTjSlg%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 788d2827ffc6693d-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
|